INGREZZA® (valbenazine) Second Quarter Net Product Sales of $440 Million Representing 26% Year-Over-Year Growth
INGREZZA® (valbenazine) 2023 Net Product Sales Guidance Raised to $1.77 - $1.82 Billion
https://www.biospace.com/article/releases/neurocrine-biosciences-reports-second-quarter-2023-financial-results-and-raises-2023-ingrezza-sales-guidance/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.